InBio

InBio is a biotechnology research company that specializes in allergen-related science, providing a broad range of highly purified natural and recombinant allergens, immunoassay test kits, and environmental allergen detection services. The company develops proprietary technology including monoclonal antibody portfolios and immunoassay platforms such as ELISA and MARIA, which are used to measure and analyze allergens from indoor environments, food products, and pharmaceutical compounds. By maintaining an ISO 9001:2015 certified quality management system, InBio ensures that its reagents and testing tools meet rigorous scientific standards for molecular allergy diagnostics, structural studies, and industrial hygiene applications.

These capabilities are essential for academic researchers, government agencies, and Fortune 500 companies involved in asthma and allergy studies, food safety, and immunotherapy development. InBio addresses complex challenges in allergen analysis, such as detecting contaminants in complex food matrices or characterizing proprietary compounds for pharma-grade therapies. With over 25 years of experience, significant research output through peer-reviewed publications, and expertise in navigating regulatory and diagnostic requirements, the company serves as a critical partner for organizations aiming to advance food allergy research, establish risk assessment thresholds, and improve indoor air quality standards.